Bin Li, Ph.D.
Dr. Bin Li is a Senior Principal Scientist at SSTI. His research focused on developing small molecule inhibitors for oncogenic cell signaling pathways, including Wnt signaling. Two of his publications…
Will Guerrant, Ph.D.
Dr. Will Guerrant is a Senior Principal Scientist at SSTI. His research focused on identifying targetable oncogenic biology within the Hippo-YAP pathway as potential new therapeutics for many cancers. Dr. Guerrant…
Matthew Knowe, Ph.D.
Dr. Matthew Knowe is a Principal Scientist at SSTI. He developed a novel organocatalyst for the enantioselective desymmetrization of carboxylic acids, and applied these methods towards improved synthesis of biologically…
Michael Beauzieux, M.S.
Michael Beauzieux is a Scientist at SSTI. His research focused on developing novel chemoresistant leukemia cell models. Michael received his master’s degree in Biochemistry and Molecular Biology from University of…
Samir Saleh, M.Sc.
Mr. Samir Saleh joined SSTI as a Chemist. He conducted isotopic labeling of drug analogs and metabolites for metabolic studies, and has over 40 years of experience in medicinal chemistry. Prior…
